Processa Pharmaceuticals, Inc. Proceeds from Sale of Property, Plant, and Equipment
Processa Pharmaceuticals, Inc. (PCSA) reported Proceeds from Sale of Property, Plant, and Equipment of $17.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2017-09-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment · last filed 2017-09-25
- Processa Pharmaceuticals, Inc. proceeds from sale of property, plant, and equipment for the quarter ending 2016-09-30 was -$25.00K.
- Processa Pharmaceuticals, Inc. proceeds from sale of property, plant, and equipment for the quarter ending 2016-06-30 was $15.00K.
- Processa Pharmaceuticals, Inc. proceeds from sale of property, plant, and equipment for the quarter ending 2016-03-31 was $27.00K.
- Processa Pharmaceuticals, Inc. proceeds from sale of property, plant, and equipment for fiscal 2015 was $31.10K.
| Period end | Proceeds from Sale of Property, Plant, and Equipment 2 month | Proceeds from Sale of Property, Plant, and Equipment 3 month | Proceeds from Sale of Property, Plant, and Equipment 6 month | Proceeds from Sale of Property, Plant, and Equipment 9 month | Proceeds from Sale of Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|
| 2016-09-30 | -$25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | -$10.00K derived: sum of 2 quarters · filed 2017-09-08 | $17.00K 10-Q · filed 2017-09-08 | ||
| 2016-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | $42.00K 10-Q · filed 2017-08-30 | |||
| 2016-03-31 | $27.00K 10-Q · filed 2017-08-07 | ||||
| 2015-12-31 | $31.10K 10-K · filed 2017-09-25 | ||||
| 2015-11-24 | $3.50K 10-Q · filed 2015-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |